Ensign Peak Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,070
Closed -$35K 2040
2022
Q3
$35K Hold
12,070
﹤0.01% 2265
2022
Q2
$42K Hold
12,070
﹤0.01% 2081
2022
Q1
$57K Hold
12,070
﹤0.01% 2111
2021
Q4
$73K Buy
+12,070
New +$83.8K ﹤0.01% 2109

Other funds holding MDXG

Ensign Peak Advisors's MDXG Position: Q4 2022 in Review

Ensign Peak Advisors sold out of MiMedx Group (MDXG) in Q4 2022, closing a stake of 12,070 shares — an estimated $35K sold.

Ensign Peak Advisors first reported a position in MDXG in Q4 2021 and held it in 4 quarters. The position peaked at $73K in Q4 2021. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2022.

  • Ensign Peak Advisors reported no remaining MiMedx Group position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 12,070 MiMedx Group shares in Q4 2022, an estimated $35K.
  • Ensign Peak Advisors first reported a position in MiMedx Group in Q4 2021 and held it in 4 quarters.
  • Ensign Peak Advisors's MiMedx Group position peaked at $73K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.